Trilogy Mets

Trilogy Metals rose ~4.8% to $3.06 during regular trading, driven by clarity on the federal permitting timeline for its Arctic Project announced alongside Q2 results. The company reported a net loss of $6.35M, or $(0.04)/share, with the loss widening 191.5% YoY, though operating loss narrowed sequentially to $2.09M from $4.62M. Key catalyst: the publication of a federal and state permitting schedule targeting a Record of Decision by September 2028. Despite the session gain, the stock remains 72.9% below its 52-week high of $11.29 and is trading below both its 20-day ($3.13) and 60-day ($3.75) moving averages, while post-market ticks fell to $2.92, reflecting lingering caution on valuation.

Trilogy Metals closed the regular session up 6.71% at $3.18, rebounding from a low open, primarily driven by the morning announcement of a federal and state permitting schedule for the Arctic Project, establishing a defined timeline toward a Record of Decision by September 2028. The stock hit an intraday high of $3.195 before dipping to $2.98 in the afternoon, then recovered, with post-market trading extending to $3.19. However, the stock remains 71.83% below its 52-week high of $11.29 and well under its 60-day MA of $3.888, with a YTD decline of 30.72%. The Q2 2026 earnings report showed a net loss widening to $6.345 million, with EPS of -$0.04, worsening year-over-year, though the company stated cash is sufficient to meet 2026 needs.

Trilogy Metals opened lower and drifted downward during regular trading, closing at $2.975, down 2.0% from the prior close, driven by a disappointing Q2 earnings release showing no revenue and a widened net loss. The stock briefly edged up to $3.148 in pre-market before gapping down to $3.035 at the open, reaching an intraday low of $2.895 before a slight recovery. Q2 net loss widened 191.5% YoY to $6.345 million, with EPS at -$0.04 and operating loss of $2.09 million, up 26.8% YoY. Positively, the company disclosed that its Arctic project has been accepted into the FAST-41 federal permitting program, targeting a Record of Decision by September 2028, and extended the U.S. Department of War strategic equity investment closing deadline to July 31. However, continued losses without revenue weighed on sentiment. The stock trades 73.7% below its 52-week high of $11.29, 107.7% above the low of $1.43, well below both the 20-day MA of $3.37 and 60-day MA of $3.955, with a YTD decline of 35.3%. The commencement of the 2026 summer field program may provide future catalysts.

Trilogy Metals experienced a rally-and-retreat pattern today, driven by its Q2 net loss widening to $6.35M (YoY -191%) and EPS of -$0.04 (YoY -201.7%), with zero revenue highlighting fundamental weakness. The stock hit an intraday high of $3.375 before declining to close at $3.14, down 2.8% from the prior close of $3.23, with a slight recovery to $3.179 in post-market trading. Price-wise, it remains 72% below its 52-week high of $11.29, well below both MA20 ($3.50) and MA60 ($4.024), and has fallen 31.6% year-to-date. However, recent FAST-41 federal permitting progress and insider purchases of 5,000 shares may offer some support.

Trilogy Metals traded lower during the regular session, last at $3.045 as of 11:43 AM ET, down approximately 4.5% from the prior close, pressured by the company's Q2 2026 net loss of $6.35 million and EPS of -$0.04, a 95% year-over-year loss expansion, with zero revenue as the project remains in exploration. The stock declined from an intraday high of $3.218 to a low of $3.031, with 413,509 shares traded, following a weak pre-market. The price is 73% below the 52-week high of $11.29, and trades below both the 20-day MA ($3.57) and 60-day MA ($4.071), with a YTD decline of 33.66%. However, the company's Arctic Project received FAST-41 federal permitting status and the U.S. Department of War equity investment deadline was extended to July 31, though near-term focus remains on persistent losses and no revenue.